CHMP recommends restricting the use of Richter's Esmya

Ball now in European Commission's court

Hungary Richter stakeholder crosses north of 5% threshold

Hungary to go on with COVID drug trial

Remdesivir research continues despite WHO statement

Hungary to test favipiravir coronavirus drug

Clinical trials begin in five locations

Sanofi Hungary to upgrade syringe plant for HUF 7 bn

Increasing capacity by 50%

ANALYST VIEW - Drug of Hungary's Richter could be facing new rival

Jefferies publishes opinion

EU, AstraZeneca sign deal on COVID-19 vaccine

British drugmaker to supply 300 mn doses

Hungarian state ownership in Richter decreases

Share transfer to foundation closed

ANALYST VIEW - Jefferies ups target price for Hungary's Richter

Share price close to all-time high

Richter receives marketing authorisation for Libdree in UK

Hungary Richter Q2 results beat expectations

Vraylar sales skyrockets, revenue rises

EU signs deal with Gilead to supply COVID-19 drug

EUR 63 mn for 30,000 doses of remdesivir

ANALYST VIEW - Jefferies reviews Richter 'wonder' drug

Vraylar sequential growth to continue after lockdown

EU approves Covid-19 drug remdesivir

Gilead’s Veklury first to get go-ahead

ANALYST VIEW - J.P. Morgan cuts target price for Hungary's Richter

Rating is overweight

ANALYST VIEW - Jefferies publishes research on Hungary's Richter

Target price, rating remain unchanged

Richter to pay HUF 63 dividend per share

Hungary Richter lowers 2020 sales target

It revises EBIT forecast upwardly, though

Hungary Richter posts record revenue in Q1 2020

Exceeds profit expectations

Hungary Richter expected to report sales close to previous record

First quarter turned out well, according to analysts